Key result
Hypertension is linked to ~2.4-fold higher monthly medical costs in men with stage 2 disease.
Why the study?
Hypertension and related cardiovascular diseases may lead to increased long-term medical costs, but the relationship over a 10-year period was unclear.
Cohort (n=4,191)
No
Absolute Event Rate: 15756% vs 6694%
p-value: p=<0.01
May inform resource allocation for hypertension care in men; extends cost estimates but leaves causal effects on total expenditures open.
Hypertension and related cardiovascular diseases may lead to an increase in medical costs for patients. We attempted to clarify the relationship between hypertension and long-term medical costs by a cohort study utilizing existing data as well as baseline blood pressures and medical costs over a 10-year period. The participants included 4191 Japanese National Health Insurance beneficiaries aged 40-69 years, living in one area, who were not taking anti-hypertensive medication and did not have a history of major cardiovascular disease. They were classified into four categories according to their blood pressure. We evaluated the mean medical costs per month, cumulative hospitalization, and all-cause mortality for each blood pressure category. Hypertension-related medical costs attributable to hypertensive individuals, as compared to normotensive individuals, were estimated. There was a positively graded correlation between blood pressure and personal total medical costs, especially for men. The odds ratio for cumulative hospitalization and hazard ratio for all-cause mortality in severe hypertensive men were also higher than those in normotensive men. However, the hypertension-related medical costs for mild to moderate hypertensives were higher than those for severe hypertensives. The hypertension-related medical costs for all hypertensives accounted for 23.7% of the total medical costs for the Japanese population. In conclusion, high blood pressure was a useful predictor for excess medical costs; moreover, concomitant hypertension, regardless of the grade, increased the medical costs of Japanese National Health Insurance beneficiaries.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2005) conducted a cohort in Hypertension (n=4,191). Hypertension vs. Normotension was evaluated on Personal total medical costs per month (adjusted geometric mean in JPY) for men with stage 2 hypertension vs normotension (p=<0.01). Hypertension was positively correlated with personal total medical costs, particularly in men, and hypertension-related medical costs accounted for 23.7% of the total medical costs for the population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: